New implantable device could revolutionize opioid overdose response
A swine model to demonstrate the potential of an implantable system for opioid safety (iSOS).
A swine model to demonstrate the potential of an implantable system for opioid safety (iSOS).
SciSparc will earn royalties from the commercialisation of the pain therapy. Credit: Wasan Tita/Shutterstock. Israel-based pharmaceutical company SciSparc has signed an exclusive patent licence agreement
With the latest BTD, ENHERTU has now received eight designations, four of which are for metastatic breast cancer. Credit: Peakstock/Shutterstock. Daiichi Sankyo and AstraZeneca‘s ENHERTU
Explore the risk of persistence of adolescent depressive symptoms into young adulthood.
The long-term subjective cognitive decline risk associated with Herpes zoster infections.
LIVDELZI is intended to be used in combination with ursodeoxycholic acid for PBC patients. Credit: Gilead Sciences, Inc./ Business Wire. Gilead Sciences has formed a
The acquisition will aid Lilly in enhancing treatment options for individuals suffering from IBD. Credit: Tada Images/Shutterstock. Eli Lilly and Company has concluded the acquisition
The association between gut microbiota (GM) composition and incident fractures in the Finnish Risk Monitoring Program (FINRISK) 2002 cohort.
SALT LAKE CITY — On paper, Recursion Pharmaceuticals shouldn’t have worked. The company — or, at least, what existed at its founding in 2013 — hoped
The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients, but suffering often doesn’t just afflict the patient. It can